4//SEC Filing
Stilley William B. III 4
Accession 0001213900-23-000003
CIK 0001513525other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:02 AM ET
Size
5.0 KB
Accession
0001213900-23-000003
Insider Transaction Report
Form 4
Stilley William B. III
DirectorChief Executive Officer10% Owner
Transactions
- Disposition to Issuer
Common Stock
2022-12-30−166,667→ 1,020,979 total
Footnotes (1)
- [F1]Represents the cancellation of 166,667 previously outstanding shares of restricted common stock of Adial Pharmaceuticals, Inc. originally issued on February 23, 2022.
Documents
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001718069
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 6:02 AM ET
- Size
- 5.0 KB